Q3 2022 Holdings
Filed 2022-11-14 | 85 holdings | $728.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $119.4M | 2,465,016 | 16.4% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $94.6M | 1,115,949 | 13.0% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $88.5M | 3,383,233 | 12.1% |
| Centene Corp del(CNC) | COM | 15135B101 | $86.6M | 1,112,480 | 11.9% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $74.1M | 1,659,733 | 10.2% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $63.3M | 6,000,000 | 8.7% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $42.6M | 317,163 | 5.8% |
| Avantor Inc(AVTR) | COM | 05352A100 | $40.8M | 2,079,657 | 5.6% |
| Biogen Inc(BIIB) | COM | 09062X103 | $37.2M | 139,326 | 5.1% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $37.0M | 104,732 | 5.1% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $27.2M | 2,162,411 | 3.7% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $10.0M | 9,320,584 | 1.4% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $4.3M | 397,711 | 0.6% |
| Celcuity Inc(CELC) | COM | 15102K100 | $1.4M | 140,426 | 0.2% |
| Lilly ELI & Co(LLY) | COM | 532457108 | $96.6K | 298,643 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $80.6K | 166,066 | 0.0% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $76.2K | 571,936 | 0.0% |
| Penumbra Inc(PEN) | COM | 70975L107 | $68.3K | 360,030 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $67.6K | 1,091,840 | 0.0% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $61.9K | 493,721 | 0.0% |
| Erasca Inc(ERAS) | COM | 29479A108 | $56.7K | 7,264,981 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $56.3K | 111,554 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $50.9K | 840,238 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $50.0K | 365,215 | 0.0% |
| OAK STR Health Inc | NOTE 3/1 | 67181AAB3 | $48.9K | $63,000,000 | 0.0% |
| Molina Healthcare Inc(MOH) | COM | 60855R100 | $47.4K | 143,779 | 0.0% |
| Aerie Pharmaceuticals Inc | NOTE 1.500%10/0 | 00771VAB4 | $47.4K | $48,150,000 | 0.0% |
| Biomarin Pharmaceutical Inc | NOTE 0.599% 8/0 | 09061GAH4 | $45.6K | $45,910,000 | 0.0% |
| Select Sector Spdr TR(XLK)Put | TECHNOLOGY | 81369Y803 | $45.6K | 383,500 | 0.0% |
| Danaher Corporation(DHR) | COM | 235851102 | $45.4K | 175,690 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $44.9K | 2,393,311 | 0.0% |
| Biogen Inc(BIIB)Call | COM | 09062X103 | $44.5K | 166,800 | 0.0% |
| Cardinal Health Inc(CAH) | COM | 14149Y108 | $42.7K | 639,783 | 0.0% |
| Iqvia Hldgs Inc(IQV) | COM | 46266C105 | $41.5K | 229,081 | 0.0% |
| Verve Therapeutics Inc | COM | 92539P101 | $40.1K | 1,168,808 | 0.0% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $39.7K | 3,805,370 | 0.0% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $39.7K | 480,256 | 0.0% |
| Penumbra Inc(PEN)Call | COM | 70975L107 | $39.3K | 207,500 | 0.0% |
| Cigna Corp New(CI) | COM | 125523100 | $39.2K | 141,300 | 0.0% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $36.0K | 105,811 | 0.0% |
| Point Biopharma Global Inc | COM | 730541109 | $34.9K | 4,515,216 | 0.0% |
| Veeva SYS Inc(VEEV) | CL A COM | 922475108 | $33.4K | 202,387 | 0.0% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $32.2K | 175,235 | 0.0% |
| Waters Corp(WAT) | COM | 941848103 | $31.7K | 117,634 | 0.0% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $31.6K | 576,800 | 0.0% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $31.5K | 62,143 | 0.0% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $31.0K | 360,520 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $31.0K | 1,289,073 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $29.3K | 130,293 | 0.0% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $28.1K | 544,583 | 0.0% |